Institutional investors purchased a net $4.7 million shares of INVA during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 75.59% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 1.1 Million shares of Innoviva Inc